Vaccinex, Inc.
VCNX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001205922
No open-market purchases or sales by Vaccinex, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Vaccinex, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- −1 vs. Q3 2023
- Shares held
- 1.60M
- −979.7K (−37.9%) vs. Q3 2023
- Total value
- $1.07M
- −$1.85M (−63.5%) vs. Q3 2023
- New holders
- 4
- 4 more added
- Sold out
- 5
- 4 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VCNX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $45 |
| Q3 2024 | 12 | $1.14M |
| Q2 2024 | 11 | $1.81M |
| Q1 2024 | 12 | $2.39M |
| Q4 2023 | 18 | $1.07M |
| Q3 2023 | 19 | $2.92M |
| Q2 2023 | 23 | $994.8K |
| Q1 2023 | 24 | $1.10M |
| Q4 2022 | 25 | $3.12M |
| Q3 2022 | 22 | $2.28M |
| Q2 2022 | 27 | $5.03M |
| Q1 2022 | 25 | $5.49M |
| Q4 2021 | 21 | $1.66M |
| Q3 2021 | 23 | $3.36M |
| Q2 2021 | 28 | $4.54M |
| Q1 2021 | 33 | $2.79M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Vaccinex, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 294 | $0 | 0.00% | 00.0% | Unchanged |
| Financial Connections Group, Inc. | 270 | $0 | 0.00% | +270 | New |
| Bank of America Corp | 4 | $3 | 0.00% | −63−94.0% | Reduced |
| JPMorgan Chase & Co | 10 | $7 | 0.00% | +7+233.3% | Added |
| Cornerstone Planning Group LLC | 14 | $9 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 20 | $13 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 68 | $45 | 0.00% | +31+83.8% | Added |
| Advisor Group Holdings, Inc. | 234 | $155 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 339 | $225 | 0.00% | −12,271−97.3% | Reduced |
| Group One Trading, L.P. | 916 | $609 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 6,656 | $4.43K | 0.00% | +6,122+1,146.4% | Added |
| XTX Topco Ltd | 11,737 | $7.80K | 0.00% | +11,737 | New |
| Geode Capital Management, LLC | 16,100 | $10.7K | 0.00% | +20.0% | Added |
| Two Sigma Investments, LP | 16,159 | $10.7K | 0.00% | +16,159 | New |
| Renaissance Technologies LLC | 32,100 | $21.0K | 0.00% | +32,100 | New |
| Vanguard Group Inc | 48,221 | $32.1K | 0.00% | 00.0% | Unchanged |
| Worth Venture Partners, LLC | 654,079 | $434.8K | 0.24% | −63,480−8.8% | Reduced |
| AIGH Capital Management LLC | 817,061 | $543.2K | 0.21% | −273,112−25.1% | Reduced |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −680,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −13,757−100.0% | Sold out |
| Tacita Capital Inc | 0 | $0 | 0.00% | −3,172−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −172−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −54−100.0% | Sold out |